Search Results - "Abrahamsen, J F"

Refine Results
  1. 1

    Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells by Abrahamsen, J.F., Stamnesfet, S., Liseth, K., Hervig, T., Bruserud, O.

    Published in Transfusion (Philadelphia, Pa.) (01-02-2005)
    “…BACKGROUND:  Large‐volume leukapheresis (LVL) differs from normal‐volume leukapheresis (NVL) by increased blood flow and altered anticoagulation regimen. LVL…”
    Get full text
    Journal Article
  2. 2

    Mini nutritional assessment short-form (MNA-SF) predicts institutionalisation in an intermediate post-acute care setting by Folven, Kristin Ingvaldsen, Biringer, E., Abrahamsen, J. F.

    Published in The Journal of nutrition, health & aging (01-02-2018)
    “…Objectives The aim of the study was to investigate whether nutritional status as measured by the Mini Nutritional Assessment Short-Form (MNA-SF) predicts level…”
    Get full text
    Journal Article
  3. 3

    Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases by ABRAHAMSEN, J. F, BAKKEN, A. M, BRUSERUD, Ø, GJERTSEN, B. T

    “…The number of viable precursor cells actually reinfused into patients after high-dose chemotherapy is one of the most clinically important variables…”
    Get full text
    Journal Article
  4. 4

    Three different outcomes in older community-dwelling patients receiving intermediate care in nursing home after acute hospitalization by Abrahamsen, Jenny Foss, Haugland, C., Nilsen, R. M., Ranhoff, A. H.

    Published in The Journal of nutrition, health & aging (01-04-2016)
    “…Objectives To evaluate the recovery and outcome of older communitydwelling patients admitted to intermediate care (IC) in nursing homes after acute…”
    Get full text
    Journal Article
  5. 5

    Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age by Abrahamsen, J F, Andersen, A, Hannisdal, E, Nome, O, Abrahamsen, A F, Kvaløy, S, Høst, H

    Published in Journal of clinical oncology (01-02-1993)
    “…In the period 1968 through 1988, The Norwegian Radium Hospital (NRH) treated an unselected population of 1,152 patients with Hodgkin's disease (HD) that…”
    Get more information
    Journal Article
  6. 6

    Insulin‐Like Growth Factor‐1 (IGF‐1) has a Costimulatory Effect on Proliferation of Committed Progenitors Derived from Human Umbilical Cord CD34+ Cells by Frostad, S., Bjerknes, R., Abrahamsen, J. F., Olweus, J., Bruserud, Ø.

    Published in Stem cells (Dayton, Ohio) (01-01-1998)
    “…The effects of insulin‐like growth factor‐1 (IGF‐1) on highly enriched human umbilical cord CD34+ cells were investigated in vitro. CD34+ cells were cultured…”
    Get full text
    Journal Article
  7. 7

    DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients by SMAALAND, R, ABRAHAMSEN, J. F, SVARDAL, A. M, LOTE, K, UELAND, P. M

    Published in British journal of cancer (01-07-1992)
    “…DNA cell cycle distribution and glutathione (GSH) content in bone marrow were measured both at daytime and midnight over single 24 h periods in 15 cancer…”
    Get full text
    Journal Article
  8. 8

    Variation in cell yield and proliferative activity of positive selected human CD34+ bone marrow cells along the circadian time scale by Abrahamsen, J. Foss, Smaaland, Rune, Sothern, Robert B., Laerum, Ole Didrik

    Published in European journal of haematology (01-01-1998)
    “…: Variations in cell yield and proliferative activity of human bone marrow (BM) progenitor cells were determined with flow cytometry along the 24‐h (circadian)…”
    Get full text
    Journal Article
  9. 9

    Circadian cell cycle variations of erythro- and myelopoiesis in humans by Abrahamsen, Jenny Foss, Smaaland, Rune, Sothern, Robert B., Laerum, Ole Didrik

    Published in European journal of haematology (01-05-1997)
    “…:  By use of a multiparameter flow cytometric method with specific surface markers, circadian (24‐h) variations in cell cycle distribution have been studied in…”
    Get full text
    Journal Article
  10. 10

    The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft by Liseth, K., Foss Abrahamsen, J., Bjørsvik, S., Grøttebø, K., Bruserud, Ø

    Published in Cytotherapy (Oxford, England) (2005)
    “…DMSO is widely used as a cryoprotectant for PBPC. It is desirable to reduce the amount of DMSO without jeopardizing the quality of the stem cell product. The…”
    Get full text
    Journal Article
  11. 11

    Flow cytometric measurement of DNA S-phase in human bone marrow cells: correcting for peripheral blood contamination by Abrahamsen, J F, Smaaland, R, Skjaerven, R, Laerum, O D

    Published in European journal of haematology (01-03-1996)
    “…The relationship between bone marrow (BM) cells with S-phase DNA content and the amount of peripheral blood contamination estimated as percentage…”
    Get more information
    Journal Article
  12. 12

    Circadian variation in serum cortisol and circulating neutrophils are markers for circadian variation of bone marrow proliferation in cancer patients by Abrahamsen, J F, Smaaland, R, Sandberg, S, Aakvaag, A, Lote, K

    Published in European journal of haematology (01-04-1993)
    “…Serum cortisol, circulating white blood cells and DNA cell cycle distribution in bone marrow cells were measured during daytime (11.00) and at midnight (24.00)…”
    Get more information
    Journal Article
  13. 13

    Bone marrow examination in Hodgkin's disease by Abrahamsen, A F, Jakobsen, E, Langholm, R, Abrahamsen, J F, Kvaløy, S, Nome, O

    Published in Acta oncologica (1992)
    “…Bone marrow aspiration and biopsy was performed as part of routine staging in 425 patients with primary Hodgkin's disease. Only seven patients were found to…”
    Get more information
    Journal Article
  14. 14

    No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide by Bakken, A M, Bruserud, O, Abrahamsen, J F

    “…High-dose chemotherapy with autologous stem cell rescue usually requires cryopreservation of the cells. For several years, 10% dimethyl sulfoxide (DMSO) has…”
    Get more information
    Journal Article
  15. 15

    Peripheral blood progenitor cell grafts contain high levels of platelet-secreted mediators by Foss, Brynjar, Abrahamsen, Jenny Foss, Bruserud, Øystein

    Published in Transfusion (Philadelphia, Pa.) (01-11-2001)
    “…BACKGROUND: The cytokine network in peripheral blood progenitor cell (PBPC) grafts may affect hematopoietic reconstitution or the risk of postransplant relapse…”
    Get full text
    Journal Article
  16. 16

    Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse? by Bruserud, O, Foss, B, Abrahamsen, J F, Gjertsen, B T, Ernst, P

    “…Conventional chemotherapy of acute myelogenous leukemia (AML) results in an overall long-term disease-free survival of less than 50%, but for selected subsets…”
    Get more information
    Journal Article
  17. 17

    Predictors for return to own home and being alive at 6 months after nursing home intermediate care following acute hospitalization by Abrahamsen, J.F, Haugland, C, Nilsen, R.M, Ranhoff, A.H

    Published in European geriatric medicine (01-04-2014)
    “…Abstract Purpose To investigate factors associated with ability to return home and being alive at 6 months, in a population of older community living patients…”
    Get full text
    Journal Article
  18. 18

    Current concepts for chronochemotherapy of cancer by Laerum, O D, Smaaland, R, Abrahamsen, J F

    “…In this article, a survey on the concepts and scientific basis for applying chemotherapy against malignant tumors on a circadian schedule is given. The idea is…”
    Get more information
    Journal Article
  19. 19

    Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study by Abrahamsen, J F, Fosså, S D

    Published in Strahlentherapie und Onkologie (01-09-1990)
    “…48 patients with muscle invasive bladder cancer were asked by a mailed questionnaire concerning post-radiotherapy functional status, urological and intestinal…”
    Get more information
    Journal Article
  20. 20